Why the study?
Does early ICD implantation improve cost-effectiveness and mortality compared to conventional antiarrhythmic drug strategy in postinfarct sudden death survivors?
Does early ICD implantation improve cost-effectiveness and mortality compared to conventional antiarrhythmic drug strategy in postinfarct sudden death survivors?
Early ICD implantation is more cost-effective than conventional antiarrhythmic drug therapy in postinfarct sudden death survivors, supporting its use as a primary strategy.
No takes yet. Share an insight, caveat, or question.
Supports early ICD as cost-effective strategy post-MI; extends limited trial data for guideline adoption.
Richard N.W. Hauer (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: